Changes of high mobility group box 1 in serum of pig acute hepatic failure model and significance

Abstract

The role of the high mobility group box 1 (HMGB-1) in acute hepatic failure and the effect of artificial liver support system treatment on HMGB-1 level were investigated. Pig models of acute hepatic failure were induced by D-galactosamine and randomly divided into two groups with or without artificial liver support system treatment. Tumor necrosis factor-α (TNF-α) and interleukin-1_β (IL-1_β) levels were detected by the enzyme linked immunosorbent assay (ELISA), the expression of HMGB-1 by Western blot, and serum levels of HMGB-1, liver function and hepatic pathology were observed after artificial liver support system treatment. The levels of TNF-α and IL-1_β were increased and reached the peak at 24th h in the acute hepatic failure group, then quickly decreased. The serum level of HMGB-1 was increased at 24th h in the acute hepatic failure group and reached the peak at 48th h, then kept a stable high level. Significant liver injury appeared at 24th h and was continuously getting worse in the pig models of acute hepatic failure. In contrast, the liver injury was significantly alleviated and serum level of HMGB-1 was significantly decreased in the group treated with artificial liver support system (P<0.05). It was suggested that HMGB-1 may participate in the inflammatory response and liver injury in the late stage of the acute liver failure. Artificial liver support system treatment can reduce serum HMGB-1 level and relieve liver pathological damage.

Keywords

high mobility group box 1 / liver failure / artificial liver support system treatment

References

[1] BustinM.. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci, 2001, 26: 152-153

[2] ThomasJ. O.. HMGB-1 and 2: architectural DNA-binding proteins. Biochem Soc Trans, 2001, 29: 395-401

[3] WangH., BloomO., ZhangM., et al.. HMGB-1 as a late mediator of endotoxin lethality in mice. Science, 1999, 285(5425): 248-251

[4] RolandoN., WadeJ., DavalosM., et al.. The systemic inflammatory response syndrome in acute liver failure. Hepatology, 2000, 32: 734-739

[5] BonaldiT., TalamoF., ScaffidiP., et al.. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J, 2003, 22: 5551-5560

[6] LotzeM. T., TraceyK. J.. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol, 2005, 5: 331-342

[7] AnderressonU., TraceyK. J.. HMGBI in sepsis. Scand J Infect Dis, 2003, 35: 577-587

[8] TsungA., SahaiR., TanakaH., et al.. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med, 2005, 201: 1135-1143

[9] ItoT., KawaharaK., NakamuraT., et al.. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost, 2007, 5: 109-116